Skip to main content
Figure 1 | BMC Urology

Figure 1

From: The primary therapy chosen for patients with localized prostate cancer between the university hospital and its affiliated hospitals in Nara Uro-oncological research group registration

Figure 1

The distribution of the preferential primary therapy (A), the actual primary therapy for all 1609 patients (B), in NMU hospital (C), and in the affiliated hospitals (D) for the patients with cT1-2N0M0 (Chi-square test; = 0.001, NMU hospital vs. affiliated hospitals). NMU; Nara Medical University, RP; radical prostatectomy, PADT; primary androgen deprivation therapy, HDR; high dose rate brachytherapy, BT; brachytherapy, EBRT; external beam radiation therapy, WW; watchful waiting.

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us